Pull to refresh
Logo
What Changed
Following Why Sign Up
Fujifilm launches Synapse Pathology v3.0 with AI foundation model

Fujifilm launches Synapse Pathology v3.0 with AI foundation model

New Capabilities

Digital pathology platform adds AI orchestration and a research foundation model, plus a UK case-outsourcing workflow

October 23rd, 2026: Fujifilm UK and Source LDPath automate histology outsourcing

Overview

Updated Oct 27

Fujifilm Healthcare Americas launched Synapse Pathology v3.0 on October 12. The release adds more than 50 features, connects third-party AI tools through a hub called Synapse AI Orchestrator, and introduces Synapse Pathology AI Foundry, a foundation model trained on millions of pathology images.

Fujifilm said it would show the software at Pathology Visions 2026 in San Diego in October, including a research model that sorts gastrointestinal specimens into normal, inflammatory, atypical and malignant categories. On October 23, Fujifilm's UK arm and Source LDPath said an automated outsourcing workflow built on Synapse Pathology helped reduce turnaround times for histology cases sent for external review.

Why it matters

Pathologists face growing case volumes, and labs now need infrastructure to run multiple AI tools from different vendors without juggling separate systems.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

50+
New features in v3.0
Fujifilm says the release adds more than 50 new features and functions.
Millions
Pathology images used to train AI Foundry
The foundation model was trained on millions of pathology images.
3
Specimen types covered by Ibex integration
Ibex's AI detects malignancy in prostate, breast, and gastric specimens.

Voices

Curated perspectives — historical figures and your fellow readers.

Sign up to generate historical perspectives on this story.

Log in Sign Up

People Involved

DL
Dr. Mark Lloyd
Vice president of digital pathology, FUJIFILM Healthcare Americas Corporation
Leading Fujifilm's digital pathology division

Organizations Involved

FUJIFILM Healthcare Americas Corporation
FUJIFILM Healthcare Americas Corporation
Medical imaging company
Developer of Synapse Pathology

The Americas arm of Fujifilm's healthcare division, based in Lexington, Massachusetts.
IM
Ibex Medical Analytics
AI pathology company
Third-party AI partner

Provides AI-powered malignancy detection for prostate, breast, and gastric specimens.
AP
Aiforia and PathAI
AI pathology companies
Competitors

Announced a distribution agreement through the AISight Marketplace the same week as Fujifilm's launch.
SO
Source LDPath
Diagnostic and histopathology services provider
Partner in an automated digital outsourcing workflow with Fujifilm UK

Part of Source BioScience UK Ltd, providing histopathology and diagnostic services, including external case review for NHS laboratories.

Timeline

2023 October 2026

5 events Latest: October 23rd, 2026 · 3 weeks ago
Tap a bar to jump to that date

  1. Fujifilm UK and Source LDPath automate histology outsourcing

    Latest Partnership

    FUJIFILM Healthcare UK and Source LDPath, part of Source BioScience, said their automated digital outsourcing workflow built on Synapse Pathology sends histology cases for external review and helps cut reporting turnaround. The companies said the workflow first went live at a shared customer site in May 2025, with more sites since.

  2. Fujifilm presents AI research poster

    Conference

    Fujifilm presents 'From Diagnostic to Prognostic Risk Scores in GI Cancers' at Pathology Visions reception, display #9.

  3. Synapse Pathology v3.0 launches

    Product Launch

    Fujifilm launched Synapse Pathology v3.0 with 50+ new features, AI orchestration, and the Synapse Pathology AI Foundry foundation model.

  4. Fujifilm shows Synapse Pathology v3.0 at Pathology Visions 2026

    Conference

    Fujifilm staffed booth #603 at Pathology Visions 2026 in San Diego, where it planned to show Synapse Pathology v3.0 and the foundation model for screening.

  5. Fujifilm acquires Dynamyx

    Acquisition

    Fujifilm acquired Dynamyx, which became Synapse Pathology, its digital pathology PACS platform.

Scenarios

1

Synapse Pathology AI Foundry gains FDA clearance for clinical use

Possible Resolves by End of 2027

Discussed by: Medspark and industry analysts

The foundation model is research-use-only today. If clinical validation studies show diagnostic accuracy, Fujifilm could pursue FDA clearance and deploy the model in routine case review. The company's Pathology Visions poster on prognostic risk scores in GI cancers is a step toward clinical validation.

2

AI orchestration becomes the standard for multi-vendor pathology AI

Likely Resolves by Q2 2027

Discussed by: Newsy USA and Fujifilm

Labs run multiple AI models: one to triage, one to measure, one to classify. Fujifilm's Synapse AI Orchestrator routes cases to the right algorithm and keeps an audit trail. If major labs adopt this model, orchestration could become the standard way to run AI in pathology.

3

Aiforia-PathAI partnership challenges Fujifilm's market lead

Possible Resolves by Q2 2027

Discussed by: Medspark

Aiforia and PathAI announced a distribution agreement through the AISight Marketplace the same week. A wave of vendors is racing to place AI models inside routine case review. Whether foundation models translate into better diagnostic accuracy, or simply faster deployment of narrow tools, remains an open question.

4

Independent evidence undercuts the case for pathology foundation models

Possible Resolves by Oct 31, 2027

Discussed by: Researchers publishing in Nature Communications

A study of more than 100,000 prostate biopsies from 6,268 patients across 15 sites found foundation models helped when labelled data was scarce, but caught up with and sometimes fell behind task-specific models trained on enough slides. The authors also reported foundation models used up to 35 times more energy. Fujifilm has published no clinical accuracy data for AI Foundry, which is research-use-only.

Historical Context

2 moments from history that rhyme with this story — and how they unfolded.

2023-2025

Radiology AI foundation model shift (2023-2025)

Radiology vendors shifted from narrow single-task AI models to foundation models trained on broad imaging datasets. The approach spread quickly through radiology and is now reaching pathology.

Then

AI deployment in radiology accelerated as models could be adapted to multiple tasks.

Now

Foundation models became the default architecture for medical imaging AI.

Why this matters now

Fujifilm's Synapse Pathology AI Foundry applies the same pattern to pathology, training a general-purpose model on millions of pathology images.

1990s-2010s

Film-to-digital PACS transition (1990s-2010s)

Radiology departments transitioned from physical film to digital picture archiving and communication systems (PACS). The transition took more than a decade and required new infrastructure, workflows, and training.

Then

Radiologists could view images instantly and collaborate remotely.

Now

Digital imaging became the standard, enabling computer-aided diagnosis and AI.

Why this matters now

Digital pathology is following the same path, with Synapse Pathology as one of the leading platforms. The v3.0 release adds the AI infrastructure that makes the digital transition more useful.

Sources

(9)
+3
FUJIFILM Americas Newsroom Medspark TMCnet Newsy USA Fujifilm Healthcare Solutions Pathology News Source BioScience Nature Communications Fujifilm Healthcare Solutions